Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

NCT00068393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma
Renal Cell Carcinoma With Sarcomatoid Features

Interventions

DRUG: Doxorubicin
DRUG: Gemcitabine
DRUG: G-CSF (granulocyte-colony stimulating factor)
DRUG: Neulasta

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]